Search research articles
Contact Us
Filters
Showing results (111-120 of 198) with videos related to
Page
of 20
Sort By:
Cancers
|
September 10, 2021
RET Inhibitors in Non-Small-Cell Lung Cancer
Priscilla Cascetta, Vincenzo Sforza, Anna Manzo, et al.
Journal of Clinical Medicine
|
April 8, 2020
Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study
Arturo Cuomo, Marco Cascella, Cira Antonietta Forte, et al.
Cancer Biology & Therapy
|
July 27, 2010
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial
Gaetano Facchini, Michele Caraglia, Alessandro Morabito, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
March 17, 2025
Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?
Carmine Picone, Annamaria Porto, Roberta Fusco, et al.
Oncotarget
|
July 25, 2016
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma
Anna Maria Rachiglio, Riziero Esposito Abate, Alessandra Sacco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2023
Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study
Nicola Normanno, Antonella De Luca, Riziero Esposito Abate, et al.
The Oncologist
|
March 19, 2022
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion
Alessandro Morabito, Anna Manzo, Agnese Montanino, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 5, 2017
Evaluation of the VeriStrat<sup>®</sup> serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
Shirish Gadgeel, Glenwood Goss, Jean-Charles Soria, et al.
ESMO Open
|
September 11, 2020
Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
Morena Fasano, Carminia Maria Della Corte, Raimondo Di Liello, et al.
Frontiers in Oncology
|
September 16, 2022
Lurbinectedin in small cell lung cancer
Anna Manzo, Vincenzo Sforza, Guido Carillio, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 198) with videos related to
Sort By:
Page
of 20
Cancers
|
September 10, 2021
RET Inhibitors in Non-Small-Cell Lung Cancer
Priscilla Cascetta, Vincenzo Sforza, Anna Manzo, et al.
Journal of Clinical Medicine
|
April 8, 2020
Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study
Arturo Cuomo, Marco Cascella, Cira Antonietta Forte, et al.
Cancer Biology & Therapy
|
July 27, 2010
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial
Gaetano Facchini, Michele Caraglia, Alessandro Morabito, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
March 17, 2025
Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?
Carmine Picone, Annamaria Porto, Roberta Fusco, et al.
Oncotarget
|
July 25, 2016
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma
Anna Maria Rachiglio, Riziero Esposito Abate, Alessandra Sacco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2023
Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study
Nicola Normanno, Antonella De Luca, Riziero Esposito Abate, et al.
The Oncologist
|
March 19, 2022
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion
Alessandro Morabito, Anna Manzo, Agnese Montanino, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 5, 2017
Evaluation of the VeriStrat<sup>®</sup> serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
Shirish Gadgeel, Glenwood Goss, Jean-Charles Soria, et al.
ESMO Open
|
September 11, 2020
Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
Morena Fasano, Carminia Maria Della Corte, Raimondo Di Liello, et al.
Frontiers in Oncology
|
September 16, 2022
Lurbinectedin in small cell lung cancer
Anna Manzo, Vincenzo Sforza, Guido Carillio, et al.
Page
of 20